Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

Clinical trial NCT00094107 · COMPLETED

Trial details

NCT number: NCT00094107
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Skin Neoplasms

Start date: 2004-12-01
Primary completion: 2008-04-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.